Coronavirus Podcast: Racing for a vaccine

KOIN Podcasts

Safety, effectiveness dominate vaccine development discussion

A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle in March.. According to results released on Tuesday, early-stage testing showed the first COVID-19 vaccine tested in the U.S. revved up people’s immune systems the way scientists had hoped. The vaccine is made by the National Institutes of Health and Moderna Inc. (AP Photo/Ted S. Warren, File)

PORTLAND, Ore. (KOIN) — As the international race for a coronavirus vaccine rolls on, questions about how it will be developed and when it will make it to market dominate the most of the discussions.

Now, noted vaccine expert Amber Buhler returns to the KOIN podcast network to discuss some of the new tech that is speeding up the process, when a vaccine might be available and who gets it first.

We also revisit our April conversation about hydroxychloroquine and check in on where testing of it as a treatment for COVID-19 stands.

Listen to the podcast below or download it from Apple Podcasts, GooglePlay, Spotify, Stitcher or Podbean.

Follow KOIN 6 for the latest news and weather

App

Download our FREE news and weather apps for iPhone, iPad and Android. You can also follow us on Facebook, Twitter and Instagram, and sign up for our email newsletters.

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Twitter News Widget

Trending Stories

Don't Miss

More Don't Miss